Swiss National Bank Buys 400 Shares of Maximus, Inc. (NYSE:MMS)

Swiss National Bank increased its stake in shares of Maximus, Inc. (NYSE:MMS – Get Rating) by 0.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 146,207 shares of the health services provider’s stock after acquiring an additional 400 shares during the quarter. Swiss National Bank owned about 0.24% of Maximus worth $10,721,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of MMS. Bessemer Group Inc. lifted its stake in Maximus by 577.6% in the 3rd quarter. Bessemer Group Inc. now owns 576 shares of the health services provider’s stock worth $33,000 after purchasing an additional 491 shares in the last quarter. Fifth Third Bancorp increased its holdings in shares of Maximus by 588.1% in the fourth quarter. Fifth Third Bancorp now owns 578 shares of the health services provider’s stock worth $42,000 after purchasing an additional 494 shares during the last quarter. Wipfli Financial Advisors LLC bought a new stake in shares of Maximus in the third quarter worth about $47,000. CWM LLC lifted its position in shares of Maximus by 72.2% in the fourth quarter. CWM LLC now owns 916 shares of the health services provider’s stock worth $67,000 after buying an additional 384 shares in the last quarter. Finally, Ronald Blue Trust Inc. boosted its stake in Maximus by 210.6% during the fourth quarter. Ronald Blue Trust Inc. now owns 1,168 shares of the health services provider’s stock valued at $68,000 after buying an additional 792 shares during the last quarter. Institutional investors own 97.41% of the company’s stock.

Maximus Trading Up 0.1 %

MMS opened at $79.58 on Tuesday. Maximus, Inc. has a 12 month low of $54.46 and a 12 month high of $85.25. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 0.75. The stock has a 50-day moving average of $79.55 and a 200 day moving average of $74.94. The firm has a market cap of $4.84 billion, a P/E ratio of 28.32 and a beta of 0.69.

Maximus (NYSE:MMS – Get Rating) last announced its earnings results on Wednesday, May 3rd. The health services provider reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.02. Maximus had a return on equity of 15.37% and a net margin of 3.62%. The firm had revenue of $1.21 billion during the quarter, compared to analysts’ expectations of $1.20 billion. During the same quarter in the previous year, the business earned $1.07 EPS. The company’s quarterly revenue was up 2.5% on a year-over-year basis. As a group, research analysts forecast that Maximus, Inc. will post 4.29 EPS for the current year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 31st. Stockholders of record on Monday, May 15th will be issued a $0.28 dividend. The ex-dividend date of this dividend is Friday, May 12th. This represents a $1.12 annualized dividend and a dividend yield of 1.41%. Maximus’s dividend payout ratio (DPR) is presently 39.86%.

Wall Street Analyst Weigh In

MMS has been the topic of several recent research reports. StockNews.com raised Maximus from a “hold” rating to a “buy” rating in a report on Friday, May 5th. Raymond James increased their price objective on shares of Maximus from $80.00 to $100.00 and gave the company an “outperform” rating in a research report on Thursday, February 9th.

Maximus Profile

(Get Rating)

MAXIMUS, Inc engages in the operation of government health and human services programs, and the provision of technology solutions to government. It operates through the following segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers business process services (BPS), appeals and assessments, and related consulting work for U.S.